Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
In this phase II trial, we will evaluate the weekly schedule of topotecan in the first-line
treatment of elderly and/or poor performance status patients with extensive stage small cell
lung cancer. Patients eligible for this trial will be those considered poor candidates for
standard combination chemotherapy or other investigational regimens